Thomas Kuilman

4PUBLICATIONS
10CO-AUTHORS
Molecular targetsTumour immunologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 08, 2023
The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma.

Sebastiaan M Schieven, Joleen J H Traets, Alex V Vliet

|Jan 16, 2018
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.

Julia Boshuizen, Louise A Koopman, Oscar Krijgsman

|Jul 12, 2017
Phenotypic diversity drives paracrine drug tolerance.

Thomas Kuilman, Daniel S Peeper

Pageof 1